ArticleBMC nephrology2016

Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients.

Julia Smedbråten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.